The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 4,404,502 | 595,203 | SH | SOLE | 595,203 | 0 | 0 | |||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 1,338,722 | 478,115 | SH | SOLE | 478,115 | 0 | 0 | |||
BIOMEA FUSION INC | COM | 09077A106 | 843,895 | 83,554 | SH | SOLE | 83,554 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 5,771,375 | 226,684 | SH | SOLE | 226,684 | 0 | 0 | |||
CABALETTA BIO INC | COM | 12674W109 | 622,072 | 131,795 | SH | SOLE | 131,795 | 0 | 0 | |||
CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 5,131,048 | 337,347 | SH | SOLE | 337,347 | 0 | 0 | |||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 524,023 | 25,401 | SH | SOLE | 25,401 | 0 | 0 | |||
CULLINAN THERAPEUTICS INC | COM | 230031106 | 348,862 | 20,840 | SH | SOLE | 20,840 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 11,394,134 | 215,798 | SH | SOLE | 215,798 | 0 | 0 | |||
ELIEM THERAPEUTICS INC | COM | 28658R106 | 172,164 | 33,824 | SH | SOLE | 33,824 | 0 | 0 | |||
FATE THERAPEUTICS INC | COM | 31189P102 | 5,134,269 | 1,466,934 | SH | SOLE | 1,466,934 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 354,864 | 12,447 | SH | SOLE | 12,447 | 0 | 0 | |||
INSTIL BIO INC | COM NEW | 45783C200 | 7,239,929 | 107,545 | SH | SOLE | 107,545 | 0 | 0 | |||
LAKESHORE BIOPHARMA CO LTD | ORDINARY SHARES | G9845F109 | 212,157 | 307,920 | SH | SOLE | 307,920 | 0 | 0 | |||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 2,948,896 | 60,515 | SH | SOLE | 60,515 | 0 | 0 | |||
NKARTA INC | COM | 65487U108 | 3,346,129 | 740,294 | SH | SOLE | 740,294 | 0 | 0 | |||
NOVOCURE LTD | ORD SHS | G6674U108 | 6,138,073 | 392,711 | SH | SOLE | 392,711 | 0 | 0 | |||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 9,732,601 | 949,522 | SH | SOLE | 949,522 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 848,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 1,096,611 | 37,287 | SH | SOLE | 37,287 | 0 | 0 | |||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 9,965,093 | 227,047 | SH | SOLE | 227,047 | 0 | 0 | |||
TANGO THERAPEUTICS INC | COM | 87583X109 | 4,612,670 | 599,048 | SH | SOLE | 599,048 | 0 | 0 | |||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 11,246,874 | 1,348,546 | SH | SOLE | 1,348,546 | 0 | 0 | |||
TOURMALINE BIO INC | COM | 89157D105 | 748,264 | 29,104 | SH | SOLE | 29,104 | 0 | 0 | |||
ZAI LAB LTD | ADR | 98887Q104 | 2,414,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 15,134,138 | 626,932 | SH | SOLE | 626,932 | 0 | 0 | |||
ZENAS BIOPHARMA INC | COM | 98937L105 | 1,888,357 | 111,605 | SH | SOLE | 111,605 | 0 | 0 | |||
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 635,902 | 156,626 | SH | SOLE | 156,626 | 0 | 0 |